These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prevention and treatment of osteoporosis in primary care offices. Gill JM; Hoffman MK J Womens Health (Larchmt); 2003 Jun; 12(5):473-80. PubMed ID: 12869294 [TBL] [Abstract][Full Text] [Related]
26. Vitamin D therapy in clinical practice. One dose does not fit all. Ryan PJ Int J Clin Pract; 2007 Nov; 61(11):1894-9. PubMed ID: 17935548 [TBL] [Abstract][Full Text] [Related]
27. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns. Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977 [TBL] [Abstract][Full Text] [Related]
28. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates. Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663 [TBL] [Abstract][Full Text] [Related]
29. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Haugeberg G; Ørstavik RE; Uhlig T; Falch JA; Halse JI; Kvien TK Arthritis Rheum; 2002 Jul; 46(7):1720-8. PubMed ID: 12124854 [TBL] [Abstract][Full Text] [Related]
30. [What is reliable in therapy of osteoporosis?]. Ziegler R Internist (Berl); 1990 Nov; 31(11):680-8. PubMed ID: 2289853 [No Abstract] [Full Text] [Related]
31. National patterns of calcium use in osteoporosis in the United States. Stafford RS; Drieling RL; Johns R; Ma J J Reprod Med; 2005 Nov; 50(11 Suppl):885-90. PubMed ID: 16422278 [TBL] [Abstract][Full Text] [Related]
32. [Adherence with daily and weekly administration of oral bisphosphonates for osteoporosis treatment]. Bartl R; Götte S; Hadji P; Hammerschmidt T Dtsch Med Wochenschr; 2006 Jun; 131(22):1257-62. PubMed ID: 16755420 [TBL] [Abstract][Full Text] [Related]
33. [Postmenopausal osteoporosis]. László A Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134 [TBL] [Abstract][Full Text] [Related]
35. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial. Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000 [TBL] [Abstract][Full Text] [Related]
36. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]. Benucci M; Dolenti S; Saviola G; Manfredi M Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926 [TBL] [Abstract][Full Text] [Related]